# XGEVA

NDC: 55513-730
Generic name: denosumab
Labeler / Manufacturer: Amgen, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20101118

FDA application: BLA125320

## Active ingredients

- DENOSUMAB: 120 mg/1.7mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-730"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-730
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=628f0998-1206-4001-aeee-18133aa9f3bf